| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/02/2007 | US7276593 Proteins and nucleic acids encoding same |
| 10/02/2007 | US7276588 Antibody of human mitochondrial voltage dependent anion channel |
| 10/02/2007 | US7276587 Antibodies to EGFH2 polypeptides |
| 10/02/2007 | US7276586 Antibodies to a polypeptide encoded by a nucleic acid under-expressed in stomach and lung tumor |
| 10/02/2007 | US7276582 Control a mechanism of intracellular release of calcium, to control signal transmission in which intracellular calcium is involved; to control intracellular calcium release by carbonic anhydrase-related protein (CARP), to regulate or diagnose activity of IP3R |
| 10/02/2007 | US7276581 Tyrosine kinases; phosphoproteins; antibodies; transgenic mice whose somatic or germ cells express tumors |
| 10/02/2007 | US7276580 Neurotrophic factors |
| 10/02/2007 | US7276525 Administering either simultaneously or sequentially a bone morphogenic protein and a compound having a transforming growth factor-beta selective inhibitory activity, particularly 4-(4-benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
| 10/02/2007 | US7276496 Cyclic malonamides as inhibitors of Aβ protein protection |
| 10/02/2007 | US7276491 Administerng urea derivatives such as1-(3-Cyano-phenyl)-3-[4-(6-morpholin-4-ylmethyl-pyridin-3-yl)-naphthalen-1-yl]-urea for therapy of disease or condition relating to blood coagulation or fibrinolysis |
| 10/02/2007 | US7276490 Administering to the cancer cell a pharmaceutical formulation of a nucleic acid encoding and expressing a prostacyclin synthase as an active ingredient and a nucleic acid encoding and expressing a cyclooxygenase-2 |
| 10/02/2007 | US7276483 Polypeptide which interfers with amyloid formation |
| 10/02/2007 | US7276482 Peptide and peptide mimetic derivatives with integrin-inhibitors properties II |
| 10/02/2007 | US7276481 Method and composition for treatment of skeletal dysplasias |
| 10/02/2007 | US7276480 Polypeptide for preventing or reducing ischemia, systemic inflammatory response; kallikrein inhibitor Ecallantide |
| 10/02/2007 | US7276479 Methods of treating intestinal ischemia using heparin-binding epidermal growth factor |
| 10/02/2007 | US7276478 Methods of treating autoimmune diseases using IL-21 |
| 10/02/2007 | US7276477 Crystals of etanercept and methods of making thereof |
| 10/02/2007 | US7276476 Cyclosporin A, a surfactant, and an oil selected from the group consisting of anise oil, clove oil, cassia oil, cinnamon oil; ophthalmically acceptable emulsion, nonirritating |
| 10/02/2007 | US7276475 Remodeling and glycoconjugation of peptides |
| 10/02/2007 | US7276474 Methods of making and using surfactant polymers |
| 10/02/2007 | US7276365 Enzymatic peptide for diagnosis, prevention and treatment of tumors, diabetes, cirrhosis, autoimmune, graft rejection and viral diseases |
| 10/02/2007 | US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 10/02/2007 | US7276354 That is used to treat diseases including inflammatory disorders, cancer, esophageal diseases, reproductive diseases, disorders related to aberrant apoptosis regulation, and disorders related to aberrant DNA repair regulation |
| 10/02/2007 | US7276353 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 10/02/2007 | US7276349 Useful for selecting compounds that inhibit beta secretase for treatment of neurodegenerative diseases, such as Alzheimer's disease. |
| 10/02/2007 | US7276344 Osteoclastogenesis inhibitory factor protein for treating osteoporosis |
| 10/02/2007 | US7276342 Reduce body mass; obesity therapy; hyperlipemia; insulin resistance; atherosclerosis; antidiabetic agents; hypotensive agents |
| 10/02/2007 | US7276341 Methods and reagents for diagnosis of autoantibodies |
| 10/02/2007 | US7276333 Viral infection inhibitor targeting integrase N-terminal domain |
| 10/02/2007 | US7276248 Conjugate having a cleavable linkage for use in a liposome |
| 10/02/2007 | US7276245 Administering a botulinum toxin |
| 10/02/2007 | US7276242 Fowl pox viral construct composed of a first nucleic acid molecule encoding HIV Gag and/or Pol or derivatives and a second nucleic acid molecule encoding gamma-interferon and derivatives, effective in inducing, enhancing or otherwise stimulating an immune response to Gag and/or Pol. |
| 10/02/2007 | US7276241 Anticancer agents; administering polypeptide antagonist |
| 10/02/2007 | US7276240 Antibodies to novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 10/02/2007 | US7276239 Recombinant A2-specific TNFα-specific antibodies |
| 10/02/2007 | US7276236 Methods of preparing immune globin and uses thereof |
| 10/02/2007 | US7276235 Tissue glue with improved antiadhesive properties |
| 10/02/2007 | US7276233 Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy |
| 10/02/2007 | US7276227 Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 10/02/2007 | CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 10/02/2007 | CA2096407C Retroviral protease inhibitors |
| 09/30/2007 | CA2541701A1 Use of streptococcus suis 38 kda polypeptide as an immunogen |
| 09/27/2007 | WO2007109677A2 A novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 09/27/2007 | WO2007109673A2 Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor |
| 09/27/2007 | WO2007109668A2 Compositions and methods for improving bone mass through modulation of novel receptors of pth and fragments thereof |
| 09/27/2007 | WO2007109648A2 Compositions and methods for modulating store-operated calcium entry |
| 09/27/2007 | WO2007109620A2 Macrocyclic peptides and methods for making and using them |
| 09/27/2007 | WO2007109609A2 Method for inhibiting angiogenesis |
| 09/27/2007 | WO2007109605A2 Pharmaceutical compositions |
| 09/27/2007 | WO2007109604A2 Pharmaceutical compositions |
| 09/27/2007 | WO2007109582A2 Method of treating pulmonary edema or pulmonary inflammation |
| 09/27/2007 | WO2007109530A1 Cyclosporin a compositions |
| 09/27/2007 | WO2007109363A2 Methods and compositions for inhibiting impdh isoform 1 |
| 09/27/2007 | WO2007109303A2 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| 09/27/2007 | WO2007109299A2 Peptide |
| 09/27/2007 | WO2007109247A2 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same |
| 09/27/2007 | WO2007109230A2 Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith |
| 09/27/2007 | WO2007109118A2 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS |
| 09/27/2007 | WO2007109110A2 Methods for increasing the size of animals using needleless delivery constructs |
| 09/27/2007 | WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | WO2007108554A1 Peptide having anti-hypertensive activity |
| 09/27/2007 | WO2007108530A1 Muscle fatigue remedy |
| 09/27/2007 | WO2007108505A1 Erythropoietin solution preparation |
| 09/27/2007 | WO2007108292A1 Neurite elongation inducer |
| 09/27/2007 | WO2007107981A2 Methods, compositions and devices for maintaining chemical balance of chlorinated water |
| 09/27/2007 | WO2007107929A1 Method and composition for protection against radiation |
| 09/27/2007 | WO2007107759A1 Peptide derived from colostrum |
| 09/27/2007 | WO2007107654A1 Cyclopeptide with anti-cancer activity derived from collagen type iv |
| 09/27/2007 | WO2007107573A1 Use of polypeptides having antimicrobial activity |
| 09/27/2007 | WO2007107328A2 Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue |
| 09/27/2007 | WO2007106997A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers |
| 09/27/2007 | WO2007106991A1 Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
| 09/27/2007 | WO2007106987A1 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
| 09/27/2007 | WO2007106986A1 Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
| 09/27/2007 | WO2007106951A1 Antimicrobial protein |
| 09/27/2007 | WO2007106938A1 Method of treatment or prophylaxis inflammatory pain |
| 09/27/2007 | WO2007089950A3 Preparations of growth hormone |
| 09/27/2007 | WO2007087428A3 Thrombopoietic compounds |
| 09/27/2007 | WO2007059955A3 Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| 09/27/2007 | WO2007057872A3 Casein-derived antimicrobial peptides and lactobacillus strains that produce them |
| 09/27/2007 | WO2007056510A3 Chloride transport upregulation for the treatment of traumatic brain injury |
| 09/27/2007 | WO2007056195A3 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 09/27/2007 | WO2007055388A3 Calcium receptor activator |
| 09/27/2007 | WO2007054911A8 Compositions useful for recovering original trophism and pigmentation, and for stimulating growth of the integumentary apparatus, uses and products thereof . |
| 09/27/2007 | WO2007050485A3 Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension |
| 09/27/2007 | WO2007047653A3 Synthetic hla binding peptide analogues of mutant v617f jak2 enzyme and uses therefor |
| 09/27/2007 | WO2007044758A3 Anti-neoplastic agent combination therapy and method of administration thereof |
| 09/27/2007 | WO2007035757A3 Composition and method for treating iron deficiency anemia |
| 09/27/2007 | WO2007019273A3 Phosphorylation of tau by abl |
| 09/27/2007 | WO2007011819A3 Ferritin as a therapeutic target in abnormal cells |
| 09/27/2007 | WO2006088491A3 Methods and compositions related to the modulation of intercellular junctions |
| 09/27/2007 | WO2006066064A3 A voltage-gated, ph-sensitive anion channel and its novel splice variant involved in taste sensation |
| 09/27/2007 | WO2006047315A3 Targeted delivery of biological factors using self-assembling peptide nanofibers |
| 09/27/2007 | WO2006017318A3 Methods for treating cancer using agents that inhibit wnt16 signaling |
| 09/27/2007 | WO2005046583A3 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 09/27/2007 | WO2004073504A3 Methods for the treatment and prevention of diseases of biological conduits |
| 09/27/2007 | US20070226815 Protein with immunomodulatory activity, antiviral activity, and antitumor activity encoded by a IFN-alpha upregulated gene; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals, primers, probes, antibodies |
| 09/27/2007 | US20070225631 Sealants for Skin and Other Tissues |
| 09/27/2007 | US20070225358 Dimeric compounds and thier use as anti-viral agents |